PL2490684T3 - Sposoby i formulacje odżywcze dla zwiększenia skuteczności i zmniejszenia skutków ubocznych leczenia nowotworu - Google Patents
Sposoby i formulacje odżywcze dla zwiększenia skuteczności i zmniejszenia skutków ubocznych leczenia nowotworuInfo
- Publication number
- PL2490684T3 PL2490684T3 PL10825771T PL10825771T PL2490684T3 PL 2490684 T3 PL2490684 T3 PL 2490684T3 PL 10825771 T PL10825771 T PL 10825771T PL 10825771 T PL10825771 T PL 10825771T PL 2490684 T3 PL2490684 T3 PL 2490684T3
- Authority
- PL
- Poland
- Prior art keywords
- efficacy
- methods
- reduce
- increase
- side effects
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G06—COMPUTING OR CALCULATING; COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q10/00—Administration; Management
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
- A23L13/60—Comminuted or emulsified meat products, e.g. sausages; Reformed meat from comminuted meat product
- A23L13/65—Sausages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P20/00—Coating of foodstuffs; Coatings therefor; Making laminated, multi-layered, stuffed or hollow foodstuffs
- A23P20/20—Making of laminated, multi-layered, stuffed or hollow foodstuffs, e.g. by wrapping in preformed edible dough sheets or in edible food containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Business, Economics & Management (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Operations Research (AREA)
- Entrepreneurship & Innovation (AREA)
- Quality & Reliability (AREA)
- Strategic Management (AREA)
- Tourism & Hospitality (AREA)
- Physics & Mathematics (AREA)
- General Business, Economics & Management (AREA)
- General Physics & Mathematics (AREA)
- Theoretical Computer Science (AREA)
- Human Resources & Organizations (AREA)
- Marketing (AREA)
- Economics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25415409P | 2009-10-22 | 2009-10-22 | |
| EP10825771.8A EP2490684B1 (en) | 2009-10-22 | 2010-10-22 | Methods and nutritional formulations to increase the efficacy and reduce the side effects of cancer treatment |
| PCT/US2010/053821 WO2011050302A2 (en) | 2009-10-22 | 2010-10-22 | Methods and nutritional formulations to increase the efficacy and reduce the side effects of cancer treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2490684T3 true PL2490684T3 (pl) | 2018-07-31 |
Family
ID=43900993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10825771T PL2490684T3 (pl) | 2009-10-22 | 2010-10-22 | Sposoby i formulacje odżywcze dla zwiększenia skuteczności i zmniejszenia skutków ubocznych leczenia nowotworu |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20110118528A1 (pl) |
| EP (1) | EP2490684B1 (pl) |
| JP (1) | JP2013508411A (pl) |
| CN (1) | CN102753162A (pl) |
| AU (2) | AU2010310515B2 (pl) |
| BR (1) | BR112012009423A2 (pl) |
| CA (1) | CA2779282C (pl) |
| DK (1) | DK2490684T3 (pl) |
| ES (1) | ES2659353T3 (pl) |
| PL (1) | PL2490684T3 (pl) |
| PT (1) | PT2490684T (pl) |
| RU (1) | RU2549954C2 (pl) |
| WO (1) | WO2011050302A2 (pl) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2888811C (en) * | 2012-10-22 | 2023-10-24 | University Of Southern California | A diet package, and uses thereof |
| CN114236130A (zh) * | 2013-02-12 | 2022-03-25 | 南加利福尼亚大学 | 用于减轻年龄相关症状的膳食包装 |
| US9386790B2 (en) * | 2013-07-01 | 2016-07-12 | University Of Southern California | Fasting condition as dietary treatment of diabetes |
| US10172839B2 (en) | 2014-03-06 | 2019-01-08 | University Of Southern California | Use of short term starvation regimen in combination with kinase inhibitors to enhance traditional chemo-drug efficacy and feasibility and reverse side effects of kinases in normal cells and tissues |
| WO2015134837A2 (en) * | 2014-03-06 | 2015-09-11 | University Of Southern California | Use of short term starvation regimen in combination with kinase inhibitors to enhance traditional chemo-drug efficacy and feasibility and reverse side effects of kinases in normal cells and tissues |
| CA2944088C (en) * | 2014-03-28 | 2022-06-21 | L-Nutra Inc. | Tyrosine kinase inhibitors for use in a method of treating cancer in association with a reduced caloric intake |
| EP3125904A4 (en) * | 2014-04-02 | 2017-08-30 | University of Southern California | Autoimmunity and multiple sclerosis treatment |
| KR20180002677A (ko) * | 2015-04-16 | 2018-01-08 | 유니버시티 오브 써던 캘리포니아 | 라파마이신 및 덱사메타손에 의해 유도된 표준 및 고 글루코스 조건에 대응하여 정상 세포를 보호하고 암 감작 조건을 생성하는 금식 모방 규정식(fmd) 및 글루코스 저하 약물 |
| BR112017023748A2 (pt) | 2015-05-06 | 2018-07-31 | University Of Southern California | métodos para tratar hipertensão; reduzir níveis de colesterol elevados e/ou níveis de ldl elevados; reduzir níveis de triglicerídeo elevados e/ou níveis de crp elevados; tratar um indivíduo com níveis de insulina ou glicose elevados; tratar obesidade abdominal; tratar um indivíduo com níveis de igf-1 elevados; tratar ou prevenir inflamação; aumentar regeneração; e reduzir fígado gorduroso |
| RU2018114459A (ru) * | 2015-09-21 | 2019-10-23 | Ифом Фондационе Иституто Фирк Ди Онколоджа Молеколаре | Новые стратегии лечения рака крови |
| CN108463121A (zh) * | 2016-01-12 | 2018-08-28 | 南加利福尼亚大学 | 长期禁食模仿作为多发性骨髓瘤和其它癌症的膳食治疗的用途 |
| KR20180120153A (ko) | 2016-02-15 | 2018-11-05 | 유니버시티 오브 써던 캘리포니아 | 당뇨병 및 기타 질환 치료를 위한 배아형 재생을 자극하는 약물 조합물 및 방법 |
| US12042477B2 (en) * | 2016-02-23 | 2024-07-23 | Cancer Research Technology Limited | Dietary product devoid of at least two non essential amino acids |
| AU2017261723B2 (en) | 2016-05-11 | 2023-02-09 | University Of Southern California | Fasting mimicking diet (FMD) as an immunoregulatory treatment for gastrointestinal autoimmune/inflammatory diseases. |
| IT201700008499A1 (it) * | 2017-01-26 | 2018-07-26 | Univ Degli Studi Genova | Composizione dietetica per la prevenzione e/o il trattamento dell’iperplasia dell’endometrio |
| US11284640B2 (en) | 2017-02-14 | 2022-03-29 | University Of Southern California | Fasting mimicking diet |
| CN107951892A (zh) * | 2018-01-19 | 2018-04-24 | 丽水学院 | 锌原卟啉在制备增强人结直肠癌细胞对5-氟尿嘧啶化疗敏感性药物中的应用 |
| MX2020009613A (es) | 2018-03-15 | 2021-02-26 | Univ Southern California | Dieta que imita el ayuno (fmd) pero no ayuno solo con agua, promueve la reversion de la inflamacion y patologia de la enfermedad de intestino irritable (ibd). |
| WO2020015842A1 (en) * | 2018-07-18 | 2020-01-23 | Michalsen Andreas | Effects of a short-term fasting mimicking diet on quality of life and tolerance to chemotherapy in patients with cancer |
| CA3119100C (en) | 2018-11-09 | 2024-06-04 | Valter D. Longo | Nutrition bar for intermittent fasting-mimicking |
| CA3134756A1 (en) | 2019-04-30 | 2020-11-05 | Valter D. Longo | Fasting-mimicking diet (fmd) as an intervention for alzheimer's disease (ad) |
| JP6747702B1 (ja) * | 2019-05-10 | 2020-08-26 | 株式会社医療情報技術研究所 | 栄養処方管理システム |
| PH12021552866A1 (en) | 2019-05-14 | 2022-11-07 | Tyme Inc | Compositions and methods for treating cancer |
| IT201900009954A1 (it) * | 2019-06-24 | 2020-12-24 | Fondazione Irccs Istituto Naz Dei Tumori | Preparazione alimentare a basso contenuto calorico per l’alimentazione di pazienti affetti da neoplasie |
| WO2021118324A1 (ko) * | 2019-12-13 | 2021-06-17 | 서울대학교산학협력단 | 암의 예방 또는 치료용 약학 조성물 |
| IT202000007153A1 (it) | 2020-04-03 | 2021-10-03 | Ifom Fondazione St Firc Di Oncologia Molecolare | Apporto calorico ridotto e immunoterapia per il trattamento del cancro |
| US10905698B1 (en) | 2020-05-14 | 2021-02-02 | Tyme, Inc. | Methods of treating SARS-COV-2 infections |
| US12220402B2 (en) | 2020-06-03 | 2025-02-11 | Faeth Therapeutics, Inc. | Formulations for personalized methods of treatment |
| WO2021247923A1 (en) | 2020-06-04 | 2021-12-09 | Faeth Therapeutics, Inc. | Personalized methods of treating cancer |
| TW202227113A (zh) * | 2020-12-01 | 2022-07-16 | 南加州州立大學 | 模擬禁食飲食提升急性淋巴母細胞白血病模型中的無癌存活 |
| US20240000125A1 (en) * | 2020-12-17 | 2024-01-04 | Fondazione Irccs Istituto Nazionale Dei Tumori | Diet preparation for the nutrition of cancer patients with a restricted calorie intake |
| EP4066823B1 (en) | 2021-03-30 | 2025-04-30 | IFOM - Istituto Fondazione di Oncologia Molecolare ETS | Reduced caloric intake and anticancer agents for the treatment of cancer |
| CN115590963A (zh) * | 2022-07-13 | 2023-01-13 | 复旦大学（Cn） | 酮体、酮体诱导剂和生酮组合物中的至少一种在治疗和/或预防血小板减少症药物中的应用 |
| EP4599826A1 (en) | 2024-02-06 | 2025-08-13 | IFOM - Istituto Fondazione di Oncologia Molecolare ETS | Leucine for use in the treatment of cancer |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2074731C1 (ru) * | 1994-12-29 | 1997-03-10 | Игорь Александрович Бойко | Фитокомплекс, обладающий противоопухолевым действием, и способ лечения онкологических больных |
| CN1315473C (zh) * | 1997-03-17 | 2007-05-16 | 英国技术集团国际有限公司 | 治疗组合物 |
| AU5319499A (en) * | 1999-07-22 | 2001-02-13 | Ivan L. Cameron | Fatty acids to minimize cancer therapy side effects |
| JP4625156B2 (ja) * | 2000-04-10 | 2011-02-02 | イーエヌ大塚製薬株式会社 | 癌化学療法に伴う副作用軽減剤 |
| WO2005117542A2 (en) * | 2004-05-10 | 2005-12-15 | Novacea, Inc. | Treatment of pancreatic cancer with active vitamin d compounds in combination with other treatments |
| WO2006043966A2 (en) * | 2004-10-15 | 2006-04-27 | University Of Tennessee Research Foundation | Methods for inducing apoptosis in adipocytes |
| US20070116802A1 (en) * | 2005-11-23 | 2007-05-24 | Carl Germano | High quality caloric composition |
| US20080038367A1 (en) * | 2006-08-11 | 2008-02-14 | Sal Saloum | Nutritional supplement compositions and methods of preparing |
| RU2354369C2 (ru) * | 2007-03-16 | 2009-05-10 | Михаил Владимирович Кутушов | Применение родамина 6ж в качестве лекарственного средства для лечения злокачественных новообразований и амилоидозов |
| EP2156188B1 (en) * | 2007-03-28 | 2021-05-05 | University of Southern California | Induction of differential stress resistance and uses thereof |
| CA2706656A1 (en) * | 2007-11-26 | 2009-06-04 | Nestec S.A. | Compositions and methods for inhibiting the activation of dsrna-dependent protein kinase and tumor growth inhibition |
-
2010
- 2010-10-22 CA CA2779282A patent/CA2779282C/en active Active
- 2010-10-22 CN CN2010800560747A patent/CN102753162A/zh active Pending
- 2010-10-22 DK DK10825771.8T patent/DK2490684T3/en active
- 2010-10-22 EP EP10825771.8A patent/EP2490684B1/en active Active
- 2010-10-22 WO PCT/US2010/053821 patent/WO2011050302A2/en not_active Ceased
- 2010-10-22 ES ES10825771.8T patent/ES2659353T3/es active Active
- 2010-10-22 PT PT108257718T patent/PT2490684T/pt unknown
- 2010-10-22 JP JP2012535426A patent/JP2013508411A/ja active Pending
- 2010-10-22 RU RU2012118588/15A patent/RU2549954C2/ru active
- 2010-10-22 US US12/910,508 patent/US20110118528A1/en not_active Abandoned
- 2010-10-22 AU AU2010310515A patent/AU2010310515B2/en active Active
- 2010-10-22 PL PL10825771T patent/PL2490684T3/pl unknown
- 2010-10-22 BR BR112012009423A patent/BR112012009423A2/pt not_active Application Discontinuation
-
2016
- 2016-03-11 AU AU2016201607A patent/AU2016201607B2/en active Active
-
2021
- 2021-03-17 US US17/204,419 patent/US20210209516A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2010310515A1 (en) | 2012-05-17 |
| EP2490684B1 (en) | 2018-01-03 |
| JP2013508411A (ja) | 2013-03-07 |
| US20110118528A1 (en) | 2011-05-19 |
| PT2490684T (pt) | 2018-04-02 |
| US20210209516A1 (en) | 2021-07-08 |
| ES2659353T3 (es) | 2018-03-14 |
| BR112012009423A2 (pt) | 2017-06-13 |
| RU2012118588A (ru) | 2013-11-27 |
| AU2016201607A1 (en) | 2016-03-31 |
| RU2549954C2 (ru) | 2015-05-10 |
| DK2490684T3 (en) | 2018-04-09 |
| EP2490684A4 (en) | 2016-05-04 |
| WO2011050302A3 (en) | 2011-08-25 |
| AU2016201607B2 (en) | 2017-11-30 |
| CA2779282A1 (en) | 2011-04-28 |
| WO2011050302A2 (en) | 2011-04-28 |
| AU2010310515B2 (en) | 2016-01-07 |
| CA2779282C (en) | 2017-12-05 |
| CN102753162A (zh) | 2012-10-24 |
| EP2490684A2 (en) | 2012-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2490684T (pt) | Métodos e formulações nutricionais para aumentar a eficácia e reduzir os efeitos secundários do tratamento oncológico | |
| ZA201207574B (en) | Phytocannabinoids in the treatment of cancer | |
| ZA201302979B (en) | Dianosis and treatment relating to th2 inhibition | |
| EP2645957A4 (en) | ELIMINATION OF FAT BY NON-INVASIVE HYPERTHERMIC TREATMENT | |
| PL3208612T3 (pl) | Kompozycje i sposoby leczenia chorób o podłożu immunologicznym | |
| SG10201509279QA (en) | Compositions and methods for the prevention and treatment of cancer | |
| IL218575A0 (en) | Treatment of cancer | |
| PL2510072T3 (pl) | Terapeutyczne i kosmetyczne kompozycje elektroluminescencyjne | |
| ZA201300692B (en) | Administration of hypoxia activated prodrugs and antiagiogenic agents for the treatment of cancer | |
| SG10201508495VA (en) | Combination treatment of cancer | |
| IL214349A0 (en) | Compositions and methods for the treatment of cancer | |
| EP2651894A4 (en) | THIOSEMICARBAZONE COMPOUNDS FOR CANCER TREATMENT | |
| IL214757A0 (en) | Compositions and methods to prevent and/or treat cancer with pa-card | |
| PL2375912T3 (pl) | Kompozycje i sposoby leczenia uczucia dyskomfortu gardła | |
| ZA201408057B (en) | Compositions and methods for the treatment of moderate to severe pain | |
| IL233080A0 (en) | Bisarylsulfonamides used to treat inflammation and cancer | |
| GB201718726D0 (en) | Phytocannabinoids in the treatment of cancer | |
| IL216717A0 (en) | USE OF BENZYDAMINE IN THE TREATMENT OF p40-DEPENDENT DISEASES | |
| EP2480099A4 (en) | COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING METABOLIC DISEASES | |
| GB0916686D0 (en) | Treatment of cancer | |
| ZA201005770B (en) | The treatment of damaged skin | |
| HUP1000688A2 (en) | Use of trifluoro-phthalimides in the treatment of cancer | |
| GB201020304D0 (en) | Treatment and prevention of pain | |
| AU2010904813A0 (en) | Skin cancer prevention and treatment | |
| AU2010900897A0 (en) | Skin cancer prevention and treatment |